Literature DB >> 12672678

Metabolic predictors of 5-year change in weight and waist circumference in a triethnic population: the insulin resistance atherosclerosis study.

Elizabeth J Mayer-Davis1, Gregory J Kirkner, Andrew J Karter, Daniel J Zaccaro.   

Abstract

Insulin resistance, insulin secretion, and glucose tolerance may predict weight change. A total of 1,194 adults aged 39-69 years at baseline (46% with normal glucose tolerance according to World Health Organization criteria, 23% with impaired glucose tolerance, and 31% with type 2 diabetes mellitus who were not taking insulin) were evaluated at baseline (1992-1994) and after 5 years. Baseline insulin sensitivity (S(I)) was measured by means of a 12-sample, insulin-enhanced, frequently sampled intravenous glucose tolerance test. Insulin secretion was assessed in terms of acute insulin response and disposition index, both obtained from the frequently sampled intravenous glucose tolerance test. At follow-up, 25% of subjects had lost more than 2.27 kg (>5 pounds), 38% weighed within 2.27 kg of their baseline weight, and 37% had gained more than 2.27 kg. In separate models, greater weight loss occurred among those with type 2 diabetes than among those with either impaired glucose tolerance or normal glucose tolerance (p < 0.001); baseline acute insulin response and disposition index were positively associated and baseline fasting insulin level was inversely associated with 5-year weight change (p < 0.05 for each; data were adjusted for baseline body mass index and demographic and behavior change variables). Upon simultaneous inclusion of metabolic variables within glucose tolerance status groups, none was a significant predictor of weight loss. Apart from glucose tolerance status itself, measures of insulin metabolism appear to have little effect on weight change over 5 years.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12672678     DOI: 10.1093/aje/kwg022

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  7 in total

1.  Nine-year changes in cardiovascular disease risk factors with weight maintenance in the atherosclerosis risk in communities cohort.

Authors:  Kimberly P Truesdale; June Stevens; Jianwen Cai
Journal:  Am J Epidemiol       Date:  2007-01-27       Impact factor: 4.897

2.  Insulin resistance influences weight loss in non-obese women who followed a home-based exercise program and slight caloric restriction.

Authors:  Mauro Felippe Felix Mediano; Rosely Sichieri
Journal:  Diabetes Res Clin Pract       Date:  2011-04-03       Impact factor: 5.602

3.  Hospital improvement in time to reperfusion in patients with acute myocardial infarction, 1999 to 2002.

Authors:  Robert L McNamara; Jeph Herrin; Elizabeth H Bradley; Edward L Portnay; Jeptha P Curtis; Yongfei Wang; David J Magid; Martha Blaney; Harlan M Krumholz
Journal:  J Am Coll Cardiol       Date:  2005-12-13       Impact factor: 24.094

4.  Relationship between insulin sensitivity and long-term weight change in adults.

Authors:  Aaron M Potretzke; Meghan Warren; Kathryn H Schmitz; Tara S Gottsacker; Michael D Jensen
Journal:  Endocr Pract       Date:  2011 Jan-Feb       Impact factor: 3.443

Review 5.  Associations between gender, age and waist circumference.

Authors:  J Stevens; E G Katz; R R Huxley
Journal:  Eur J Clin Nutr       Date:  2009-09-09       Impact factor: 4.016

6.  Body weight, not insulin sensitivity or secretion, may predict spontaneous weight changes in nondiabetic and prediabetic subjects: the RISC study.

Authors:  Eleni Rebelos; Elza Muscelli; Andrea Natali; Beverley Balkau; Geltrude Mingrone; Piermarco Piatti; Thomas Konrad; Andrea Mari; Ele Ferrannini
Journal:  Diabetes       Date:  2011-05-26       Impact factor: 9.461

7.  Trends of obesity and abdominal obesity in Tehranian adults: a cohort study.

Authors:  Farhad Hosseinpanah; Maryam Barzin; Parvin Sarbakhsh Eskandary; Parvin Mirmiran; Fereidoun Azizi
Journal:  BMC Public Health       Date:  2009-11-23       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.